# Does Extra-High Dose Hepatitis B Vaccination Confer Longer Serological Protection in Peritoneal Dialysis Patients?

> **NCT00125775** · PHASE4 · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 130 (estimated)

## Conditions studied

- Peritoneal Dialysis
- Renal Disease, End-Stage

## Interventions

- **BIOLOGICAL:** Engerix-B

## Key facts

- **NCT ID:** NCT00125775
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2010-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00125775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00125775, "Does Extra-High Dose Hepatitis B Vaccination Confer Longer Serological Protection in Peritoneal Dialysis Patients?". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT00125775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*